Image For Activity Cover
Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review (JACC June 2021-1)

Given the rapid pace of development and availability of new oral antineoplastic agents, the purpose of this review is to provide clinicians with an up-to-date practical approach to monitoring and management of cardiovascular toxicities with the aim of improving overall outcomes for patients with cancer.


Valentin Fuster, MD, PhD, MACC

CME Editor
Ragavendra R. Baliga, MD

Rupal O’Quinn, MD

Michael G. Fradley, MD

Atul R. Chugh, MD 

Vijay U. Rao, MD, PHD

Important Dates

Date of Release: May 24, 2021
Term of Approval/Date of CME/MOC/ECME Expiration: May 23, 2022

Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
Android App Download IOS App Download Powered By